Please assess the completion status of the following clinical trial:

Trial Title: Vaccination Against Influenza in Autoimmune Diseases

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients presenting autoimmune and systemic diseases,~* treating or not with steroids, and/or immunosuppressants and/or biotherapies, especially vasculitis, scleroderma, Sjogren's syndrome and systemic lupus (main groups)~Exclusion Criteria:~* Absence of informed consent~* Disease which did not responded to the above criteria~* Active infection at time of vaccination~* HIV infection~* History of Guillain-Barre syndrome~* Allergy to one component of the vaccine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Evaluation of vaccines against flu (Type: EXPERIMENTAL): Evaluation of vaccines against flu

Based on this trial design, predict the completion outcome and termination type (if applicable).